This article is available to HHCN+ members When Amedisys Inc. (Nasdaq: AMED) acquired Contessa Health for $250 million in 2021, it changed the home-based ...

UnitedHealth Group and Amedisys have pushed back the closure date for their $3.3 billion merger as they fend off a federal ...

Amedisys, Inc. (NASDAQ:AMED – Get Free Report) was the recipient of a significant drop in short interest in December. As of ...

The acquisition was originally expected to close this month, but in November the DOJ sued to block the merger.

Amedisys’ AMED growth in the third quarter of 2024 was driven by its continuously improving clinical quality for patients, ...

Warren Buffett has spent more than $70 million over six days to Dec. 24 to resume buying VeriSign's stock. Stronger-than-expected holiday cinema audiences brought North American box office totals to ...

Amedisys, Inc. (NASDAQ:AMED – Get Free Report)’s share price gapped up before the market opened on Friday . The stock had ...

Amedisys Inc (AMED) stock saw a modest uptick, ending the day at $89.96 which represents a slight increase of $4.01 or 4.67% from the prior close of $85.95. The stock opened at $89.5 and touched a low ...

Health-care companies fell as traders sought out sectors less vulnerable to shifting inflationary and demand trends.

February Brent crude the global benchmark, rose by 57 cents, or 0.8%, to $73.42 a barrel on ICE Futures Europe. Back on Nymex ...

The largest M&A deal for a Minnesota company announced in 2023 may be pushed into 2025 amid regulatory scrutiny.

Optum and home health provider Amedisys have extended the deadline for their proposed $3.3 billion merger amid a legal challenge from the Department of Justice. Here are 10 things to know: 1. In a Dec ...